MedPath
NMPA Approval

Recombinant Zoster Vaccine(CHO Cell)

国药准字SJ20190026

March 20, 2024

S20190026

Drug Information

重组带状疱疹疫苗(CHO细胞)

欣安立适

注射剂

复溶后每1次人用剂量0.5ml,含gE蛋白50μg。

生物制品

March 20, 2024

March 19, 2029

Company Information

Applicant Company

Rue de l`Institut 89,B-1330 Rixensart, Belgium

Manufacturing Company

Parc de la Noire Epine, 20 Avenue Fleming, 1300 Wavre, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

重组带状疱疹疫苗(CHO细胞) - NMPA 批准文号 | MedPath